Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04967365 · ClinicalTrials.gov registry record

Post-Intensive Care Syndrome - Pediatrics (PICS-p): Longitudinal Cohort Study

A clinical trial of Critical Illness and Post Intensive Care Unit Syndrome, sponsored by University of Pennsylvania.

Active
Registry status
755
Enrollment target
20
Study locations

NCT04967365: Active study of Critical Illness and Post Intensive Care Unit Syndrome, sponsored by University of Pennsylvania.

NCT04967365 is a study of Critical Illness and Post Intensive Care Unit Syndrome that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 755 participants, below the 3,130-participant average among 91 other Critical Illness trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04967365, a study of Critical Illness and Post Intensive Care Unit Syndrome, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
755 participants
Enrollment target
20
Study locations

Study Summary

Pediatric Intensive Care Unit (PICU) survival has increased substantially over the past three decades. Currently, an understanding of PICU morbidity and recovery among PICU survivors and their families is limited. Post-intensive care syndrome (PICS) consists of new or worsening impairments in physical, cognitive, or mental health status that arise and may persist after critical illness. The characteristics of PICS in children (PICS-p) are unknown. The objective of this study is to learn about pediatric recovery from critical illness to guide future intervention research to optimize child and family health.

Primary Outcome

PedsQL™ 4.0 Generic Core or Infant Scales (self report)

Study Locations (20)

California

  • Annopinder Bhalla MD - Los Angeles
  • Lucille Packard Children's Hospital Stanford - Palo Alto

Illinois

  • Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
  • Comer Children's Hospital - Chicago

Minnesota

  • Massonic Children's Hospital - Minneapolis
  • Mayo Clinic - Rochester

North Carolina

  • UNC Children's Hospital Chapel Hill - Chapel Hill
  • Brenner Children's Hospital - Winston-Salem

Alabama

  • Alabama Children's Hospital - Birmingham

Arkansas

  • Arkansas Children's Hospital - Little Rock

Colorado

  • Children's Hospital Colorado - Aurora

District of Columbia

  • Children's National Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 755 participants
Start Date 2021-07-27
Est. Completion 2026-06-30
University of Pennsylvania

1,423 total trials

What the registry record for NCT04967365 still lists

NCT04967365 is an observational study that tracks outcomes without assigning an intervention. The registered 755 participants enrollment target is mid-sized for trials with a published cap, below the 3,130-participant average among 91 other Critical Illness trials with a reported enrollment target (76% lower).

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 0 interventions.

NCT04967365 names 20 study sites across 16 states, led by California, Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04967365 about?

NCT04967365 is a clinical study titled "Post-Intensive Care Syndrome - Pediatrics (PICS-p): Longitudinal Cohort Study". Pediatric Intensive Care Unit (PICU) survival has increased substantially over the past three decades. Currently, an understanding of PICU morbidity and recovery among PICU survivors and their families is limited. Post-intensive care syndrome (PICS) consists of new or worsening impairments in physic...

What is the current status of trial NCT04967365?

This trial is currently active not recruiting. The enrollment target is 755 participants. The study started on 2021-07-27. Estimated completion is 2026-06-30.

What conditions does trial NCT04967365 study?

This clinical trial studies the following conditions: Critical Illness, Post Intensive Care Unit Syndrome.

Who is sponsoring clinical trial NCT04967365?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04967365 being conducted?

This trial has 20 study locations across Alabama, Arkansas, California, Colorado, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04967365's enrollment target sits among peer trials

755 24th of 91 higher than 68 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05869149 · 756 participants · NA

    Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial

  • NCT06095583 · 756 participants · Phase 3

    Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

  • NCT05379985 · 754 participants · Phase 1

    Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • NCT05427370 · 754 participants · NA

    The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04967365, the US trial registry maintained by the National Library of Medicine. NCT04967365 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.